LONDON: The UK's drug regulator said Saturday it had approved an updated Covid-19 jab by Pfizer/BioNTEch targeting the original virus and a subvariant ahead of an autumn booster drive.
The so-called "bivalent" jabs work for both the original virus that emerged in the Chinese city of Wuhan in 2019 and the BA.1 subvariant of Omicron.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) approved the Pfizer jab as a booster for those aged 12 and over after a "careful review of the evidence".
The UK regulator last month okayed a similar bivalent vaccine by Moderna, becoming the first country to do so.
MHRA chief executive June Raine said: "I am pleased to announce that we now have a second approved vaccine for the UK Autumn booster programme."
The National Health Service in England and Scotland will begin a fresh booster rollout on Monday, starting with care home residents and eventually inviting everyone over 50.
The other UK regions of Wales and Northern Ireland are also launching similar campaigns.
The BBC reported Saturday that the Moderna bivalent shot would be offered first, but added that the UK did not have enough supplies to cover everyone over 50.
The European Union and the United States have recently authorised the updated version of the Pfizer vaccine and Moderna vaccines.
Premier hopes crippling disease in Afghanistan would also end with international coordination, support
Researchers discover AI to be faster and accurately in detecting fatal heart issues than doctors
Elimination of such data "creates dangerous gap in scientific information, data to monitor", say health agencies
A letter seeking comprehensive surveillance was sent to airport authorities, requesting passenger details
US official expresses interest in collaborating with Pakistan to meet need of healthcare professionals
Experts say that your entire day is set by how you start your morning